William Escande

81 posts

William Escande

William Escande

@WEscande

Katılım Ekim 2014
104 Takip Edilen35 Takipçiler
William Escande retweetledi
curilakarol
curilakarol@curilakarol·
LBBP reduced non-response to BVP CRT to 50% in the dominantly non-ischemic CRT patients. The effect was seen dominantly in those with LBBB. Nice job by @xyc1982 and colleagues. Only one remark: why not randomized? jacc.org/doi/10.1016/j.…
English
1
6
23
2.1K
William Escande retweetledi
Nicolas Clementy
Nicolas Clementy@clementy_ep·
Dr Vijayaraman #HRS2023 late breaking trial: #LBBAP vs #CRT. - controlled non-randomized - 1,778 patients (!) - better echo response, better outcomes driven by HF hospitalization reduction - fewer complications
Nicolas Clementy tweet mediaNicolas Clementy tweet mediaNicolas Clementy tweet media
English
5
38
101
30.8K
William Escande retweetledi
François Braun
François Braun@FrcsBraun·
Le complotisme l’a emporté sur la science lors des débats à l’Assemblée. La vaccination est une arme de protection massive, mais les oppositions ont décidé d’envoyer un message regrettable aux soignants. Merci à la majorité présidentielle d’être restée fidèle à ses valeurs.
Français
5.4K
519
1.8K
1.5M
William Escande retweetledi
sophia aram
sophia aram@SophiaAram·
Victoire, l'alliance de l'extrême-gauche et de l'extrême-droite contre la raison et la science a enfin permis à l'obscurantisme de disposer d'une majorité à l'assemblée !!! #RéintégrationDesSoignantsNonVaccinés
sophia aram tweet media
Français
980
1.8K
5.2K
750.4K
William Escande
William Escande@WEscande·
@DariusChapman Wow can’t wait to try this innovative tool that is in need for real-time assessment of effective LBBp !
English
1
1
2
568
William Escande retweetledi
darius chapman
darius chapman@DariusChapman·
Very excited to be finished design and bench testing of the TorqView lead insertion tool, and heading to the pre-clinical lab next month. Human trials before end of 2023, and commercial release 2024!!
darius chapman tweet media
English
12
11
68
12.1K
William Escande retweetledi
Rythmo_SFC
Rythmo_SFC@rythmo_sfc·
Stim de branche gauche > un standard à l'avenir? Par @WEscande et Pr Frédéric Anselme Il nous manque encore des données pour savoir à quel patient proposer une stim branche G, des études randomisées, du suivi à long terme #JourneesStimDef2023
Rythmo_SFC tweet mediaRythmo_SFC tweet media
Français
0
4
5
791
William Escande retweetledi
Óscar Cano
Óscar Cano@OCanoPerez·
Happy to announce that the LEFT-Bundle CRT Trial (NCT05434962) is now recruiting patients. This non-inferiority multicenter (11 centers in Spain) randomized trial will compare standard BiV pacing vs. LBBAP in 176 patients @Hisdoc1 @DrRoderickTung @dontdisGD @rdschaller
Óscar Cano tweet mediaÓscar Cano tweet media
Valencia, Spain 🇪🇸 English
12
49
240
0
William Escande retweetledi
Roderick Tung
Roderick Tung@DrRoderickTung·
Congrats on showing first statistically significant benefit of conduction system pacing over the current BiV gold standard! #QSQ
Fengwei Jasper Zou@JasperZouMD

Privileged to present the LBBP-RESYNC pilot trial at the late breaking clinical trial session at #HRS2022 on behalf of Dr. Jiangang Zou. LBBP-RESYNC is the first RCT showing LBBP’s superior improvement of LVEF compared to BiV-CRT. @HRSonline

San Francisco, CA 🇺🇸 English
0
10
55
0
William Escande retweetledi
JACC Journals
JACC Journals@JACCJournals·
The #pericardium has gained increased interest of late yet its anatomy is difficult to visualize. This state-of-the-art review offers a *living* anatomy of the pericardial space — an invaluable resource for electrophysiologists. bit.ly/33mVI0x #JACCCEP #EPeeps
JACC Journals tweet media
English
0
39
121
0
William Escande retweetledi
Thomas Deneke
Thomas Deneke@EPDeneke·
#togetherVT @paolodellabella indicates MORTALITY BENEFIT of VT ablation in the PARTITA trial! Are we getting towards a class I indication?! What a great study.
Thomas Deneke tweet media
English
2
47
109
0
William Escande retweetledi
Pasquale Santangeli
Pasquale Santangeli@Dr_Santangeli·
Important data and great study
English
0
1
9
0